me-401
Showing 1 - 4 of 4
DLBCL Trial in Cleveland (ME-401, Rituximab, Cyclophosphamide)
Recruiting
- Diffuse Large B-Cell Lymphoma
- ME-401
- +5 more
-
Cleveland, OhioCleveland Clinic Taussig Cancer institute, Case Comprehensive Ca
Feb 2, 2022
Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma Trial in Japan (ME-401)
Active, not recruiting
- Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma
- ME-401
-
Nagoya, Aichi, Japan
- +5 more
Dec 10, 2021
Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Follicular Lymphoma (FL) Trial in Switzerland, United
Recruiting
- Chronic Lymphocytic Leukemia (CLL)
- +6 more
- ME-401
- +2 more
-
Tucson, Arizona
- +23 more
Dec 14, 2021
Indolent B-cell Non-Hodgkin's Lymphoma Trial in Japan (ME-401)
Active, not recruiting
- Indolent B-cell Non-Hodgkin's Lymphoma
- ME-401
-
Anjo, Aichi, Japan
- +29 more
Dec 10, 2021